Literature DB >> 1979685

Vagally induced release of gastrin, somatostatin and bombesin-like immunoreactivity from perfused rat stomach. Effect of stimulation frequency and cholinergic mechanisms.

S Madaus1, H Bender, V Schusdziarra, K Kehe, G Munzert, G Weber, M Classen.   

Abstract

The isolated stomach of rats was vascularly perfused to measure the secretion of gastrin, somatostatin (SLI) and bombesin-like immunoreactivity (BLI). The gastric lumen was perfused with saline pH 7 or pH 2, and electrical vagal stimulation was performed with 1 ms, 10 V and 2, 5 or 10 Hz, respectively. Atropine was added in concentrations of 10(-9) or 10(-7) M to evaluate the role of cholinergic mechanisms. In control experiments, vagal stimulation during luminal pH 2 elicited a significant increase of BLI secretion only at 10 Hz but not at 2 and 5 Hz. Somatostatin release was inhibited independent of the stimulation frequency employed. Gastrin secretion at 2 Hz was twice the secretion rates observed at 5 and 10 Hz, respectively. At luminal pH 7 BLI rose significantly at 5 and 10 Hz. SLI secretion was decreased by all frequencies. Gastrin secretion at 2 and 5 Hz was twice as high as during stimulation with 10 Hz. Atropine at doses of 10(-9), 10(-8), 10(-7) and 10(-6) M had no effect on basal secretion of BLI, SLI and gastrin. At luminal pH 2, atropine increased dose-dependently the BLI response at 2 and 5 but not at 10 Hz. The decrease of SLI during 2 and 5 Hz but not 10 Hz was abolished by atropine 10(-9) M. SLI was reversed to stimulation during atropine 10(-7) M at all frequencies. The rise of gastrin at 2 Hz was reduced by 50%. At luminal pH 7, atropine had comparable effects with a few differences: the BLI response at 10 Hz was augmented and the gastrin response to 2 and 5 Hz was reduced. In conclusion the present data demonstrate a frequency and pH-dependent stimulation of BLI and gastrin release. The stimulation of BLI is predominantly due to atropine-insensitive mechanisms while muscarinic cholinergic mechanisms exert an inhibitory effect on BLI release during lower stimulation frequencies (2 and 5 Hz) independent of the intragastric pH and also during higher frequencies at neutral pH. Both, atropine sensitive and insensitive mechanisms are activated frequency dependent. The atropine-sensitive cholinergic mechanisms but not the noncholinergic mechanisms involved in regulation of G-cell function are pH and frequency dependent. Somatostatin is regulated largely independent of stimulation frequency and pH by at least two pathways involving cholinergic mechanisms of different sensitivity to atropine. These data suggest a highly differentiated regulation of BLI, gastrin and SLI secretion and the interaction between these systems awaits further elucidation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979685     DOI: 10.1016/0167-0115(90)90093-c

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  Pattern-dependent vagal control of gastric secretion: the role of histamine mediation.

Authors:  V A Zolotarev; R P Khropycheva; S A Polenov
Journal:  Dokl Biol Sci       Date:  2005 Mar-Apr

2.  Peripheral mechanism of inhibitory effect of centrally administrated histamine on gastric acid secretion.

Authors:  Zhi-Fang Zhang; Zhu-Li Wang; Guang-Qi Lu
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

3.  Effects of intra-gastric beta-casomorphin-7 on somatostatin and gastrin gene expression in rat gastric mucosa.

Authors:  Ya-Feng Zong; Wei-Hua Chen; Yuan-Shu Zhang; Si-Xiang Zou
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

4.  H3-receptor regulation of vascular gastrin and somatostatin releases by the isolated rat stomach.

Authors:  A Bado; L Moizo; J P Laigneau; J Delwaide; M J Lewin
Journal:  Yale J Biol Med       Date:  1994 May-Aug

Review 5.  Adenosine: Direct and Indirect Actions on Gastric Acid Secretion.

Authors:  Rosa M Arin; Adriana Gorostidi; Hiart Navarro-Imaz; Yuri Rueda; Olatz Fresnedo; Begoña Ochoa
Journal:  Front Physiol       Date:  2017-09-22       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.